Pharmafile - Medical Communications News
A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort to persuade him to prescribe...
OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents...
Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by 2030.
With coverage of the biggest pharmaceutical merger of all time, new research which turns cancer cells to fat, as well as full-length features on how...
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning to the company to...
The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic and Analgesic Drug Products Advisory...
-Vertex ousts COO Ian Smith over 'personal behaviour'-GSK acquires #Tesaro for $5.1 bn-Canada Health approves Novartis' CAR-T therapy Kymriah-AbbVie'...
Bristol-Myers Squibb has been forced to withdraw a marketing application for its combination of Opdivo and Yervoy for lung cancer.
Amgen has announced that its PCSK9 inhibitor Repatha has secured approval by China’s drug regulator, the National Medical Products Administration (...
Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following year as the average person,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
